389 related articles for article (PubMed ID: 19913351)
1. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP
Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351
[TBL] [Abstract][Full Text] [Related]
2. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
3. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
[TBL] [Abstract][Full Text] [Related]
5. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
[TBL] [Abstract][Full Text] [Related]
8. [Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group].
Burgués JP; Conde G; Oliva J; Abascal JM; Iborra I; Puertas M; Ordoño F;
Actas Urol Esp; 2011 Sep; 35(8):439-45. PubMed ID: 21621301
[TBL] [Abstract][Full Text] [Related]
9. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
[TBL] [Abstract][Full Text] [Related]
11. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
12. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
Lipiński MI; Jeromin LM
Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
[TBL] [Abstract][Full Text] [Related]
13. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
[TBL] [Abstract][Full Text] [Related]
15. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
16. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
17. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
18. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
Naselli A; Introini C; Timossi L; Spina B; Fontana V; Pezzi R; Germinale F; Bertolotto F; Puppo P
Eur Urol; 2012 May; 61(5):908-13. PubMed ID: 22280855
[TBL] [Abstract][Full Text] [Related]
19. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]